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Introduction: No predictive models for long-term mortality in critically ill patients with acute kidney injury (AKI)
exist. We aimed to develop and validate two predictive models for one-year mortality in patients with AKI based on
data (1) on intensive care unit (ICU) admission and (2) on the third day (D3) in the ICU.
Methods: This substudy of the FINNAKI study comprised 774 patients with early AKI (diagnosed within 24 hours
of ICU admission). We selected predictors a priori based on previous studies, clinical judgment, and differences
between one-year survivors and non-survivors in patients with AKI. We validated the models internally with
bootstrapping.
Results: Of 774 patients, 308 (39.8%, 95% confidence interval (CI) 36.3 to 43.3) died during one year. Predictors
of one-year mortality on admission were: advanced age, diminished premorbid functional performance,
co-morbidities, emergency admission, and resuscitation or hypotension preceding ICU admission. The area under
the receiver operating characteristic curve (AUC) (95% CI) for the admission model was 0.76 (0.72 to 0.79) and the
mean bootstrap-adjusted AUC 0.75 (0.74 to 0.75). Advanced age, need for mechanical ventilation on D3, number of
co-morbidities, higher modified SAPS II score, the highest bilirubin value by D3, and the lowest base excess value
on D3 remained predictors of one-year mortality on D3. The AUC (95% CI) for the D3 model was 0.80 (0.75 to 0.85)
and by bootstrapping 0.79 (0.77 to 0.80).
Conclusions: The prognostic performance of the admission data-based model was acceptable, but not good. The
D3 model for one-year mortality performed fairly well in patients with early AKI.Introduction
Predictive models for mortality provide an estimate of
the probability of death in a particular group of patients.
Although they cannot replace clinical judgment in
decision-making, they are valuable complementary tools
as they can give an objective medical research-based as-
sessment of the severity of illness and the associated risk
of death [1]. A combination of a physician’s clinical evalu-
ation with a risk estimate given by a predictive model has
a better ability to distinguish patients with high or low
probabilities of survival than estimates based solely
on prediction of a physician or a model [2]. A reliable* Correspondence: meri.poukkanen@lshp.fi
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essential both for informing patients and their families
about the situation and for clinical decision-making, and
also when estimating the potential futility of care. In
addition, prediction models are useful in benchmarking,
that is, comparing the performance of intensive care units
(ICUs).
Acute kidney injury (AKI) is a syndrome that affects a
marked proportion of critically ill patients [3-5] and is
associated with high consumption of healthcare resources,
particularly when renal replacement therapy (RRT) is ad-
ministered [6-9]. AKI is associated with 90-day mortality
up to 34% [3] and an increased mortality attributable to
AKI persists up to 10 years after hospital discharge
[6,9-15]. Even mild AKI is associated with markedly in-
creased long-term mortality [16]. AKI-specific predictivetral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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poor outcome.
Models for predicting mortality, such as Acute Physi-
ology and Chronic Health Evaluation (APACHE) [17,18]
and Simplified Acute Physiology Score (SAPS) [19,20],
have shown only poor to moderate predictive perform-
ance in patients with AKI [21,22]. AKI-specific scoring
systems have been developed for prediction of hospital
[23-26] or 60-day mortality [27-29]. Some of these
models are restricted to RRT-treated patients [10,29].
None of these AKI-specific scores have used any of the
modern definitions for AKI; Risk, Injury, Failure, Loss of
kidney function, and End-stage kidney disease (RIFLE)
[30], Acute Kidney Injury Network (AKIN) [31], or Kidney
Disease: Improving Global Outcomes (KDIGO) criteria
[32]. Most importantly, these AKI-specific scoring systems
have not shown adequate discrimination or calibration
ability possibly due to significant differences in case mix,
advancements in ICU care, and changes in AKI definition
over years [21,22]. However, the predictive power of AKI-
specific models has been shown to improve with increas-
ing surveillance time [28].
One-year mortality is a relevant patient-centred out-
come compared to discharge policy-influenced hospital
mortality [33]. Accordingly, we aimed to develop and
validate predictive models for one-year mortality of crit-
ically ill patients with AKI using data available on ICU
admission and another using data collected by the third
day of ICU treatment.
Methods
Study patients
We included consecutive patients with early AKI from
the Finnish Acute Kidney Injury (FINNAKI) study [3].
The FINNAKI study was conducted in 17 Finnish ICUs
between 1 September 2011 and 1 February 2012 [3]. All
patients with an emergency admission or with elective
postoperative admission with ICU stay expected to ex-
ceed 24 hours were enrolled. The following patients
were excluded: (1) patients under 18 years of age, (2)
intermediate care patients, (3) patients with chronic dia-
lysis, (4) earlier included patients receiving RRT during
the previous admission, (5) patients transferred from an-
other study ICU, who were already included in the study
for five days, (6) patients without sufficient language
skills or without permanent residency in Finland, and (7)
organ donors. In the present study we further excluded:
(1) patients with AKI diagnosed later than 24 hours after
ICU admission, (2) all patients undergoing cardiac sur-
gery due to organizational differences in postoperative
care between the participating hospitals, and (3) all
patients in one ICU with incomplete data of vasoactive
treatment. For patients with multiple admissions, we
included the first admission with AKI.The Ethics committee of the Department of Surgery in
Helsinki University Central Hospital approved the
FINNAKI study protocol with written, informed consent
from patient or proxy and the use of deferred consent.
Finnish National Institute of Health approved the collec-
tion of data of deceased patients if informed consent could
not be obtained.
Data collection
We prospectively collected data from the first five days
in the ICU using the Finnish Intensive Care Consortium
database maintained by Tieto Ltd (Helsinki, Finland).
The data included admission and outcome data, severity
of illness scores, physiological measurements, and labo-
ratory values. Additionally, we used a study-specific case
report form (CRF) to collect information regarding prede-
termined chronic illnesses (chronic obstructive pulmonary
disease, hypertension, arteriosclerosis, systolic heart fail-
ure, chronic kidney diseases, diabetes mellitus, chronic
liver failure, ureterolithiasis, coagulopathies, systemic
vasculitis, rheumatoid arthritis, organ transplants and
malignancies), daily medications, and predetermined risk
factors for AKI (hypotension, resuscitation, hypovolaemia
by clinicans’ judgement, transfusion of at least 10 red
blood cell units, rhabdomyolysis, acute liver failure, low
cardiac output, operation within one week prior to ICU
admission, and use of radiocontrast dye/aminoglycosides/
pepticoglycans that is vancomycin/angiotensin-converting
enzyme inhibitor or angiotensin receptor blocker/
non-steroidal anti-inflammatory drugs/amphotericin
B/diuretics/metformin/hydroxylethyl starch/gelatin/albumin
within 48 hours prior to ICU admission) from patients’ re-
cords. The Finnish Population Register Centre provided
data regarding vital status at one year from ICU admission
(the primary study end point).
Definitions
We used the KDIGO criteria including both changes in
serum creatinine and hourly urine output to define and
stage AKI [32]. Early AKI was defined as any AKI stage di-
agnosed within 24 hours of ICU admission. Chronic kidney
disease was defined as glomerular filtration rate <60 ml/
ml/1.73 m2 for three months [34]. The presence of
hypotension (systolic blood pressure <90 mmHg) or resus-
citation (haemodynamic collapse requiring cardiopulmo-
nary resuscitation, defibrillation, or administration of
epinephrine) within 48 hours preceding ICU admission,
organ dysfunctions, and severe sepsis (defined according
to the American College of Chest Physicians/Society of
Critical Care Medicine criteria [35]) were evaluated by at-
tending physicians. We defined organ failure (OF) as a
daily organ-specific Sequential Organ Failure Assessment
(SOFA) score >2 [36,37]. The ΔOF was defined as the dif-
ference in the number of failed organs on day 3 (D3)
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tional performance preceding the acute illness was
dichotomised: (1) normal or unable to work but no
need for assistance in self-care and daily living and
(2) some assistance required or totally dependent on
assistance.
Model development
We generated models for one-year mortality using data
available at two clinically relevant time points: first, data
available on ICU admission (admission model) and, sec-
ond, on D3 in the ICU (D3 model). We selected candi-
date predictors for one-year mortality a priori based on
previous studies, clinical judgment as recommended [1],
and by differences in univariable analyses between one-
year survivors and non-survivors in this study. The ad-
mission model comprised only predictors available at
the time of ICU admission to avoid the possible con-
founding effect of treatment in the ICU. Age, gender,
co-morbidities, premorbid functional performance, type
of admission according to SAPS II (scheduled surgical,
unscheduled surgical, or medical), APACHE II diag-
nostic group, and presence/absence of severe sepsis were
included in both models. The admission model also in-
cluded data on presence of hypotension or resuscitation
preceding ICU admission. In the D3 model, we included
organ-supportive treatments (mechanical ventilation and
administration of norepinephrine) on D3 in the ICU,
change in the number of registered organ failures includ-
ing renal failure (ΔOF), the worst value of base excess
(BE) and platelets on the D3 in the ICU, and highest bili-
rubin concentration during the first three days in the ICU,
and SAPS II points without points for age, chronic health
status, admission type, and renal components. We studied
the potential existence of collinearity with multiplicative
terms.
First, we analysed the association between candidate
predictors and one-year mortality with multivariable
logistic regression analysis separately for both admission
and D3 models. We performed backwards elimination at
the significance level of P <0.05. We assessed discrimin-
ation (the model’s ability to distinguish survivors from
non-survivors) by concordance statistic (c-statistic) using
the area under the receiver operating characteristic
curve (AUC). We regarded AUC values of >0.7, >0.8,
and >0.9 as acceptable, good, or excellent, respectively
[39]. We evaluated calibration (the model’s ability to ac-
curately predict the number of deaths across different
levels of risk) with the Hosmer-Lemeshow goodness-of
fit (GoF) test with P value >0.05 indicating good calibra-
tion [40]. We assessed the overall predictive accuracy
with the Brier score [40], which is the mean squared dif-
ference between the observed outcome and predicted
risk of death. A low Brier score indicates good modelperformance (0 for a perfect model). When mortality is
50%, a Brier score of 0.25 would indicate that the model
is worthless; for a mortality of 40%, the upper limit of
the Brier score is 0.24 [41]. Finally, we calculated the
standardized mortality ratios (SMRs) with both models
by dividing the number of observed deaths with the pre-
dicted number of deaths.
If no data regarding pre-existing chronic illnesses were
recorded, we assumed that particular condition not to
exist [42]. For continuous data we substituted missing
values by the median value of the variable. The propor-
tion of missing data on candidate predictors ranged from
0 to 2.6% in the admission model and from 0 to 6.0% in
the D3 model.
For comparison, we determined the discrimination of
the SAPS II score when it was used alone as a predictor
of one-year mortality.
Model validation
We validated the models internally by bootstrapping.
We performed a bootstrap procedure (1,000 draws with
replacement) to obtain the bootstrap-adjusted c-statistic
index. The bootstrap method randomly draws multiple
samples with replacement from the original cohort. The
model is developed again in each bootstrap sample yield-
ing a different AUC (c-statistic) to each bootstrap model
[40]. Finally, an average of these c-indexes was calculated.
Statistical analysis
We report categorical variables as absolute numbers
with percentages and continuous data as median with
interquartile ranges (IQRs). Categorical data were com-
pared using the chi-square or Fisher’s exact test when
appropriate. We used the Mann-Whitney U test to com-
pare continuous data. We calculated the independent
contribution of each variable included in the prediction
model by dividing the difference in the −2 log likelihood
of the null model and the final model without the particu-
lar predictor by the difference in the −2 log likelihood of
the null model and the complete final model [43]. This
ratio was normalised to presents. Statistical analyses were
performed using SPSS Statistics version 20 software (IBM,
Armonk, NY, USA) and R version 3.0.3 for Mac (R Foun-
dation for Statistical Computing, Vienna, Austria).
Results
Patients
Of the 774 critically ill patients with early AKI (AKI di-
agnosed within 24 hours of ICU admission), 399 (51.6%)
stayed in the ICU for at least three days. We excluded
274 patients (24% of all 1,141 AKI patients) with AKI
occurring later than 24 hours after admission. Figure 1
illustrates the study flow chart. The overall one-year
mortality rate for patients with early AKI was 308/774
1141 patients with
AKI
274 patients in whom
AKI criteria were fulfilled
later than 24 h after ICU
admission
867 patients with AKI within 24 h
after ICU admission
53 patients with cardiac
surgery
814 patients





patients with AKI within 24 h after ICU
admission ( )
- one-year mortality 308/774 (39.8%)
375 patients with LOS
< 3 days
- one-year mortality 169/375
patients (45.1%)
1 patient with missing
Glasgow Coma Scale
from D1 to D3 excluded
398 (51.6%) patients with LOS > 3 days
( )
- one-year mortality 139/398 (34.8%)
D3-MODEL
Figure 1 Study flow chart. AKI, acute kidney injury; D1/D3, the first/third day in the ICU; ICU, intensive care unit; LOS, length of stay; SOFA,
Sequential Organ Failure Assessment.
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the 308 patients who died within one year, 222 (72%)
died in the hospital. The Kaplan-Meier one-year survival
plot is shown in Additional file 1. Table 1 presents the
characteristics of one-year survivors and non-survivors.
No differences in the proportion of patients with severe
sepsis, use of RRT in ICU, or in severity of AKI between
one-year survivors and non-survivors existed. Treatment
restrictions were applied in 202/774 (26.1%) patients.
Admission model
The admission model comprised 774 patients. Table 2
presents the results of the regression analysis with odds
ratios (OR, 95% CI) of all significant predictors. Discrim-
ination of the model was acceptable with an AUC (95%
CI) of 0.76 (0.72 to 0.79). The model was well calibrated
(Hosmer-Lemeshow GoF 10.35, P = 0.24). The mean
bootstrap-adjusted AUC of the admission model was
0.75 (95% CI 0.74 to 0.75). The Brier score yielded avalue of 0.20 (95% CI 0.20 to 0.20). The logistic regres-
sion equation and probability of death with two patient
examples are presented in Additional file 2. The bootstrap-
adjusted mean SMR (95% CI) was 1.00 (0.92 to 1.09).
Altogether 29 patients (3.7%) had a probability of death
within one year over 80%, and 24 of those 29 (82.8%) died.
Their characteristics are presented in Table 3.
In a subgroup of hospital survivors (552 patients), the
predictive ability of the admission model for the one
year mortality yielded an AUC value of 0.70 (0.64 to
0.76) with GoF 12.95, P = 0.11). Likewise, the performance
of the admission model to predict hospital mortality was
acceptable with an AUC (95% CI) of 0.76 (0.72 to 0.79)
and calibration of 7.17 by GoF, P = 0.52.
D3 model
The D3 model comprised 398 patients. Of these, 138
were dead by one year (34.7%, 95% CI 29.9 to 39.4%).
Table 4 presents the D3 model. Figure 2 illustrates the
Table 1 Characteristics of the one-year survivors and non-survivors among critically ill patients with acute kidney
injury within 24 hours of ICU admission
Data Survivors n = 466 Data Non-survivors n = 308 P
Age, years 466 62.0 (53.0-72.0) 308 70.0 (61.0-79.0) <0.001
Gender, male 466 307 (65.9) 308 199 (64.6) 0.716
Body mass index, kg/m2 465 27.8 (24.3-32.3) 306 26.5 (23.9-30.5) <0.001
Hypertension 465 249 (53.5) 306 175 (57.2) 0.320
Systolic heart failure 460 39 (8.5) 300 58 (19.3) <0.001
Arteriosclerosis 462 58 (12.6) 303 62 (20.5) 0.003
Chronic obstructive pulmonary disease 463 39 (8.4) 304 36 (11.8) 0.119
Diabetes mellitus 466 132 (28.3) 307 71 (23.1) 0.108
Malignancy 462 40 (8.7) 303 60 (19.8) <0.001
Chronic kidney disease 463 37 (8.0) 306 43 (14.1) 0.007
Chronic liver disease 463 17 (3.6) 301 27 (9.0) 0.002
Immunosuppression 442 20 (4.5) 288 28 (9.7) 0.006
Number of co-morbidities 466 1.0 (0.0-2.0) 308 2.0 (1.0-3.0) <0.001
0 co-morbidity 466 146 (31.3) 308 50 (16.2) <0.001
1-2 co-morbidities 466 223 (47.9) 308 154 (50.0) 0.559
≥3 co-morbidities 466 97 (20.8) 308 104 (33.8) <0.001
Premorbid functional performance preceding the acute illness <0.001
Normal or disabled to work but no need for assistance 465 405 (87.1) 308 238 (77.3) <0.001
Some assistance required or totally dependent on assistance 465 60 (12.9) 308 70 (22.7) <0.009
Prior to ICU admission
Hypotension prior to ICU admissiona 454 154 (33.9) 300 150 (50.0) <0.001
Resuscitation prior to ICU admissionb 466 34 (7.3) 305 55 (18.0) <0.001
Lactate prior to ICU admission, mmol/l 308 2.8 (1.5-5.3) 191 3.6 (1.5-8.1) 0.027
pH prior to ICU admission 369 7.30 (7.19-7.38) 224 7.27 (7.14-7.36) 0.111
Base excess prior to ICU admission, mmol/l 366 −6.7 (−12.5-(−2.5)) 221 −7.8 (−14.4-(−3.5)) 0.084
Creatinine prior to ICU admission, μmol/l 431 136.0 (82.0-254.0) 285 141.0 (90.0-220.0) 0.794
Platelets prior to ICU admission, E9/l 437 209.0 (141.5-282.5) 284 175.5 (101.3-266.8) 0.001
Admission type according to SAPS II
Scheduled surgical 466 23 (4.9) 308 2 (0.6) 0.001
Unscheduled surgical 466 126 (27.0) 308 65 (21.1) 0.061
Medical 466 317 (68.0) 308 241 (78.2) 0.002
SAPS II, points 466 41.0 (32.0-51.0) 308 60.0 (47.0-73.0) <0.001
SOFA D1, points 466 8.0 (6.0-11.0) 308 11.0 (9.0-14.0) <0.001
SOFA D3, points 259 7.0 (1.0-14.0) 138 9.0 (2.48-17.0) <0.001
Number of OF on D3c 255 1.0 (0.0-3.0) 138 2.0 (0.0-4.5) <0.001
0-1 OFc 255 174 (66.9) 138 65 (47.1) <0.001
2 OFc 255 61 (23.5) 138 39 (28.3) 0.29
3 OFc 255 18 (6.9) 138 24 (17.4) 0.001
≥4 OFc 255 (0.8) 138 10 (7.2) <0.001
ΔOFc,d 255 −1.0 (−3.0-1.0) 138 0 (−3.0-1.5) 0.068
During the first 3 ICU days
KDIGO stage 1 466 177 (38.0) 308 96 (31.2) 0.052
KDIGO stage 2 466 110 (23.6) 308 70 (22.7) 0.777
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Table 1 Characteristics of the one-year survivors and non-survivors among critically ill patients with acute kidney
injury within 24 hours of ICU admission (Continued)
KDIGO stage 3 without RRT 466 64 (13.7) 308 49 (15.9) 0.402
RRT 466 115 (24.7) 308 93 (30.2) 0.090
Mechanical ventilation 466 293 (62.9) 308 248 (80.5) <0.001
Severe sepsis 466 184 (39.5) 308 142 (46.1) 0.068
Length of stay (days)
ICU 466 3.4 (1.9-5.8) 308 2.7 (1.1-5.9) 0.001
Hospital 466 13.0 (8.0-23.0) 308 8.0 (3.0-18.8) <0.001
aHypotension was defined as systolic blood pressure <90 mmHg for 1 hour within 48 hours prior to ICU admission; bresuscitation was defined as haemodynamic
collapse requiring cardiopulmonary resuscitation, defibrillation or administration of epinephrine within 48 hours prior to ICU admission; cpatients with ICU stay for
at least 3 days (n = 398); dΔOF was defined as the difference in the number of organ failures on D3 versus D1. ICU, intensive care unit; SAPS, Simplified Acute
Physiology Score; SOFA, Sequential Organ Failure Assessment; KDIGO, Kidney Disease: Improving Global Outcomes; RRT, renal replacement therapy; D1/D3 the
first or third day on the ICU.
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well with an AUC (95% CI) of 0.80 (0.75 to 0.85) and
calibration of 7.70 by GoF, P = 0.46. The bootstrapped
mean AUC was 0.79 (95% CI 0.77 to 0.80). The Brier
score yielded a value of 0.17 (95% CI 0.17 to 0.18). The
logistic regression equation and calculation of the prob-
ability of death are shown in an Additional file 2. The
mean SMR (95% CI) of the bootstrapped models was
1.0 (0.89 to 1.13). Nineteen patients (4.8%) had a pro-
bability over 80% of death and 16 (84.2%) of them
died within one year. All these high-risk patients were
medical admissions, four (21.2%) required assistance
in their daily living, and they had a median (IQR) of two
(one to three) co-morbidities. Their median (IQR) ageTable 2 Admission model for one-year mortality by multivari
Odds ratio (
Age, years (per year) 1.03 (1.02-1.0
Admission type according to SAPS IIb
Unscheduled surgical 7.74 (1.65-36
Medical 11.30 (2.45-52
Chronic liver failure 3.79 (1.89-7.4
Malignancy 2.34 (1.43-3.8
Resuscitation prior to ICU admissionc 2.34 (1.42-3.8
Dependence of assistance in premorbid functional
performance preceding the acute illnessd
1.75 (1.15-2.6
Hypotension prior to ICU admissione 1.67 (1.20-2.3
Arteriosclerosis 1.87 (1.19-2.9
Diabetes mellitus 0.59 (0.41-0.8
Systolic heart failure 1.83 (1.13-2.9
Immunosuppression 1.97 (1.00-3.9
aPresents the independent contribution percentage of the variable to the predictive
was defined as haemodynamic collapse requiring cardiopulmonary resuscitation, de
admission; dcompared to normal or disable to work; ehypotension was defined as s
admission. Non-significant predictors for one-year mortality included in the analysis
Evaluation) diagnostic group, co-morbidities (hypertension, chronic obstructive pulm
admission, and severe sepsis 24 h prior to ICU. CI, confidence interval; SAPS, Simplifwas 68 (51 to 78) years, modified SAPS II score 34
(12 to 42), BE on D3 -4.7 (-7.6 to -2.1) mmol/l, and
maximum bilirubin value by D3 102 (29 to 168)
μmol/l. Eighteen (94.7%) still required mechanical
ventilation on D3. Additional file 2 presents a patient
example.
Among hospital survivors treated in the ICU for at
least three days (312 patients) the ability of the model to
predict one-year mortality yielded AUC of 0.69 (0.61 to
0.76) and calibration of 7.74 by GoF, P = 0.46.
SAPS II score
The AUC (95% CI) of the SAPS II score alone as a pre-
dictor of one-year mortality was 0.68 (0.63 to 0.74).ate logistic regression analysis














performance of the model; bcompared to scheduled surgical; cresuscitation
fibrillation or administration of epinephrine within 48 hours prior to ICU
ystolic blood pressure <90 mmHg for 1 hour within 48 hours prior to ICU
: gender, body mass index, APACHE II (Acute Physiology and Chronic Health
onary disease), glomerular filtration rate, operation within a week prior to ICU
ied Acute Physiology Score; ICU, intensive care unit.
Table 3 Characteristics of patients with over 80% risk of
death within one year according to the admission model
ADM model
(n = 29)
Age (median, IQR) 72 (67-81)
Dependence of assistance in premorbid functional
performance preceding the acute illness
12 (41.4%)
Admission type according to SAPS II
Unscheduled surgical 1 (3.4)
Medical 28 (96.6)
Arteriosclerosis 11 (37.9)
Systolic heart failure 11 (37.9)
Chronic liver failure 8 (27.6)
Diabetes mellitus 4 (13.8)
Malignancy 15 (51.7)
Immunosuppression 10 (34.5)
Hypotension prior to ICU admissiona 21 (72.4)
Resuscitation prior to ICU admissionb 16 (55.2)
aHypotension was defined as systolic blood pressure <90 mmHg for 1 hour;
bresuscitation was defined as haemodynamic collapse requiring cardiopulmonary
resuscitation, defibrillation or administration of epinephrine. ADM, admission
model; IQR, interquartile range; SAPS, Simplified Acute Physiology Score; ICU,
intensive care unit.
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In this follow-up study of the prospective FINNAKI
study, we sought to identify factors predicting one-year
mortality of critically ill patients with early AKI and to
construct predictive models for one-year mortality using
data available on ICU admission, and separately, on D3
in the ICU. Severity of the acute illness, advanced age,
diminished premorbid functional performance, a higherTable 4 Day 3 model for one-year mortality by multivariate lo
Predictor Odd
The highest bilirubin within D1 to D3 (per μmol/l)b 1.02
Age, years (per year) 1.04
Mechanical ventilation on D3 2.73
SAPS II score without points given for age, renal components,
bilirubin, and type of admission (per point)
1.03
The lowest BE value on D3 (per mmol/l) 0.92
Number of co-morbidities 1.26
Dependence of assistance in premorbid functional performance
preceding the acute illnessc
1.76
Admission type according to SAPS IId
Unscheduled surgical 3.97
Medical 6.59
aPresents the independent contribution percentage of the variable to the predictive
concentration within the first three days was 6.0%. ccompared to normal or unable to
mortality included to the analysis: APACHE II diagnostic group, gender, daily performa
D3, use of norepinephrine on D3, the lowest platelet value on the D3, the highest Kidn
difference in number of organ failures, including renal failure, on D3 and D1 (ΔOF)). CI,
Physiology Score; BE, base excess; ICU, intensive care unit.number of co-morbidities, as well as need for mech-
anical ventilation on D3 were independent predictors
of poor long-term outcome. In contrast, neither the
severity of AKI nor the presence of severe sepsis was
independently associated with one-year mortality. The
prognostic performance of the admission data-based
model was acceptable but not good. The discrimin-
ation improved with a longer surveillance period and
the performance of the D3 model was fairly good
with an AUC value of 0.8. Recently, some authors
have even considered an AUC of 0.8 excellent [44].
The SAPS II score alone was a poor predictor of long-
term outcome.
To the best of our knowledge, the current study is the
first to report models for prediction of one-year mortal-
ity in non-selected patients with early AKI. Moreover,
these models outperform the majority of previously de-
veloped models. Of previous AKI-specific scores, Liano
et al.’s score [26] performed poorly, while the SHARF
score performed fairly well with an AUC 0.8 [12]. These
models were tested among hospital survivors of the
SHARF score development cohort, and consequently,
good performance of the SHARF score was to be ex-
pected. Chertow et al. have developed predictive models
for 60-day mortality in patients with AKI of on three
separate time points (day of diagnosing AKI, day of con-
sultation of a nephrologist, and day of initiation of RRT)
[28]. Although the performance of these models im-
proved over time, the discrimination was from poor to
moderate (AUC values of 0.62, 0.68 and 0.72, respect-
ively) [28]. Among patients receiving RRT, predictive
models have performed better with AUCs from 0.83
[10] to 0.85 [29]. As RRT-treated patients form agistic regression analysis











performance of the model; bthe proportion of missing values of the bilirubin
work; dcompared to scheduled surgical. Non-significant predictors for one-year
nce, admission type according to SAPS II, severe sepsis between admission and
ey Disease: Improving Global Outcomes (KDIGO) stage during D1 to D3, and
confidence interval; D1/D3 the first or third day on the ICU; SAPS, Simplified Acute
Figure 2 Discrimination of the D3 model and SAPS II for
one-year mortality by the area under the receiver operating
characteristic curve (AUC). D3 the third day on the ICU; ICU,
intensive care unit; SAPS, Simplified Acute Physiology Score.
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models were presumably better.
At ICU admission, the three strongest predictors of
death within one year were (1) advanced age, (2) type of
ICU admission (medical or emergency surgical admis-
sion), and (3) underlying chronic liver failure contribut-
ing approximately 37% to the model. An emergency
admission has been associated with unfavourable prog-
nosis in several other models [17,19,29]. As in our
model, the presence of several co-morbidities has been
associated with one-year mortality among patients with
severe AKI [10] and also with short-term mortality in
patients with AKI [23-29]. Additionally, we found the
presence of malignancy, need for resuscitation pre-ICU,
and need for assistance in daily living to be strong pre-
dictors for one-year mortality (see Table 2). These find-
ings corroborate a recent study that found frailty among
older general ICU patients to predict six-month mortal-
ity [45]. Interestingly, diabetes was found to be a pre-
dictor for better long-term survival in the present study.
A total of 203 (26.2%) of the 774 patients with early AKI
had diabetes. In the FINNAKI study, 22.0% of the critic-
ally ill patients had diabetes and a higher proportion of
diabetes was found in patients with AKI (26.6%) than in
those without AKI (19.6%) [3]. However, the proportion
of diabetics on medication is much lower (4.5%) in the
general Finnish population [46,47]. Thus, diabetics were
relatively overrepresented in our study population. It
thus seems that diabetes predisposes to severe acute
illnesses and acute kidney injury. Nevertheless, in thispopulation of ICU patients with AKI, diabetes was associ-
ated with improved outcome. Based on our data, we are
not able to give any definitive explanation for this finding.
However, the finding is somewhat similar to the ‘obesity
paradox’: obesity increases the susceptibility for AKI, but
is associated with improved survival among patients with
RRT-treated severe AKI [48].
Most of the previous AKI-specific models are based
on data available at the time of diagnosing AKI. A worse
outcome has been found in patients with gradually pro-
gressing AKI compared to patients with stable AKI or
improving AKI [49]. In line, worsening of organ function
over the first three days after initiation of RRT or three
to four days after the onset of sepsis has been shown to
associate with decreased survival [38,50,51]. Therefore,
scores based solely on the data within the first day of
ICU or at the time of diagnosing AKI may not be reli-
able in predicting the outcome of patients with progres-
sive critical illness. In addition, previous studies have
shown the predictive performance of models among AKI
patients to improve over time [23,28]. Thus, we gener-
ated another model using data available by D3 in the
ICU. In line with other AKI-specific models, we found
that (1) advanced age, (2) need for mechanical ventila-
tion, and (3) hepatic dysfunction (the highest bilirubin
value) were the strongest predictors of long-term mor-
tality [23-26,28,29] contributing to 51% of the D3 model
(see Table 4). Of patients with a probability of over 80%
of dying, 95% needed mechanical ventilation on D3. Be-
sides advanced age, also the lowest base excess value on
D3 reflecting the severity of metabolic acidosis of vary-
ing aetiology was a predictor of worse outcome. Thus,
among patients with early AKI, other organ failures on
D3 that have been refractory to ICU treatment or have
developed while in ICU, serve as predictors of adverse
long-term outcome.
Interestingly, we did not find the presence of severe
sepsis to associate with one-year mortality. This finding
is in contrast to two AKI-specific models based on data
from years 1997 to 1998 [24] and 1999 to 2001 [28] that
have included the presence of severe sepsis as a pre-
dictor of adverse outcome. Recent studies have reported
reduced mortality in severe sepsis suggesting a beneficial
effect of increased knowledge, better recognition, and
earlier treatment of these patients [52,53]. This improved
performance in the treatment of septic patients may ex-
plain why severe sepsis did not remain as an independent
predictor in our models. Correspondingly, the increased
awareness and advances in the treatment of AKI [30-32]
may account for the somewhat unexpected finding that
severity of AKI was not an independent predictor of one-
year mortality.
A model with good performance for short-term mor-
tality also predicts long-term mortality well if most
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majority of the deaths (72%) occurred in the hospital.
This partly explains that the admission model predicted
hospital and one-year mortality equally well. Among hos-
pital survivors treated in the ICU for at least three days,
the D3 model performed worse (AUC 0.69) than it did in
the overall population, suggesting that the discrimination
ability of the D3 diminishes after hospital discharge.
Our study has several strengths. The participating
ICUs represent both academic and non-academic ICUs,
and their referral areas cover 85% of the Finnish adult
population [3]. All data were recorded prospectively. We
defined and staged AKI by changes in both serum creatin-
ine and hourly urine output with the latest AKI definition
[32]. The models comprised data that were routinely col-
lected during ICU stay and are easily repeatable. However,
several limitations need to be discussed. First, we selected
candidate predictors based on previous studies and clinical
judgement. Some significant factors may have been exclu-
ded from the analysis due to low frequency of the variable
or large proportion of missing data (we avoided including
variables with >5% of missing data) [54]. In addition, we
had to exclude 4.9% of AKI patients with missing reliable
cardiovascular SOFA score (Figure 1). Second, our study
was not multinational, which may limit the generali-
zability of the results. However, the predictors of ad-
verse outcome found in the D3 model were in line with
the previous AKI-specific models [23-29]. In addition,
the mean bootstrap-adjusted SMRs of both models sup-
port the validity of models. Third, our models include
rather many predictor variables, which may increase the
risk for overfitting. However, the large simulation study
by Vittinghoff and McCulloch demonstrated that causal
influences can generally be adequately analysed even
when there are no more than five to nine outcome
events per predictor variable [55]. Finally, though we
were not able to validate our models externally, we
used the bootstrapping technique for validation that
is considered as the preferred method for internal val-
idation [40].
Conclusions
We developed two new predictive models for one-year
mortality among critically ill patients with early AKI
using data available on ICU admission and on D3. The
prognostic performance of the admission model was ac-
ceptable, but not good, whereas the performance of the
D3 model was fairly good.
Key messages
 A predictive model for one-year mortality for
critically ill patients with early AKI based on data
on D3 performed fairly well. Severity of illness, advanced age, poor premorbid
functional performance, a high number of co-
morbidities, and need for mechanical ventilation on
D3 were predictors of a poor long-term outcome.
 Severe sepsis and the severity of AKI were not
independent predictors.
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